scorecardresearch
Add as a preferred source on Google
Saturday, December 20, 2025
TopicCovaxin

Topic: Covaxin

Covaxin neutralises double mutant Covid strain, says ICMR

The apex health research body said the National Institute of Virology has also demonstrated the neutralisation potential of Covaxin against the UK and Brazil variants.

Bharat Biotech scales up Covaxin manufacturing capacity to 700 million doses a year

The company had 200 million doses capacity when it started producing Covaxin in the beginning, say sources.

Covaxin production to increase 10 times by September, says Harsh Vardhan

Union Health Minister Harsh Vardhan also said that the manufacture of remdesivir jabs, an anti-viral drug against Covid, will be doubled to 74.1 lakh per month by May.

Russia’s Sputnik V vaccine with over 91% efficacy recommended for emergency use in India

If Modi government accepts Central Drugs and Standards Control Organisation's recommendation, Sputnik V will be the third vaccine to be used in India.

More Indians now willing to take vaccine after cases spike, Modi & ministers take shot: Survey

Survey by LocalCircles covering over 27,000 respondents says that 77% Indians are now open to being vaccinated as opposed to 38% in January.

Bharat Biotech’s Covaxin production could go up 7 times with help from Karnataka, Gujarat labs

Plan to increase Covaxin production being overseen by 6-member inter-ministerial panel appointed to augment vaccine manufacturing as Covid cases see a second wave in India.

India orders 12 crore more doses of Covishield, Covaxin at cheaper price tag of Rs 150/shot

Currently, these vaccines cost Rs 210 per dose with taxes. The additional order could lead to the domestic vaccine market opening up.

Bharat Biotech data on 43 Covid cases convinced govt to drop Covaxin from clinical trial mode

Decision to allow Covaxin to exit the clinical trial mode means the vaccine can be administered with less stringent conditions and could result in a higher intake.

Expert panel recommends Covaxin for emergency use, moves out of ‘clinical trial mode’

The recommendations were made after analysis of interim data of the phase-3 clinical trial of Bharat Biotech's Covaxin's showed the efficacy of the vaccine to be 80.6%.

Scientists oppose placebo trials for Covid vaccines, call them ‘unethical, inappropriate’

An expert group of WHO may have advocated for the continued use of blinded placebo-controlled studies for ‘reliable evidence’, but scientific community thinks otherwise. 

On Camera

Henry George’s Single Tax offers a democratic alternative to communist remedies: DM Kulkarni

The immediate benefit of Single Tax would be to reduce the sale prices of land to nominal ones. Landowners would no longer find it profitable to keep idle lands, wrote DM Kulkarni in 1960.

China is taking India to WTO over subsidies, again. Here’s what it’s arguing before trade body

Dispute will now move to consultative process, which allows the two sides to come to an amicable agreement within 60 days.

Israel has ‘realised who its real friend is’, eyes defence expansion in India amid arms curbs by others

It is argued that India-Israel ties are moving from buyer–seller dynamic to one focused on joint development & manufacturing partnership, a shift 'more durable' than traditional arms sales.

Dhurandhar shows hard cinema is soft power and Pakistan is unapologetically the target

If Pathaan gave both conservatives and liberals room to hide, Dhurandhar extends no such courtesy. Aditya Dhar ripped open that tent of hypocrisy and turned the knife.